Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer

Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer

Bibliographic Details
Main Authors:	V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320353702

Similar Items

A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer.
by: Hanting Wu, et al.
Published: (2024-01-01)

A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer
by: Hanting Wu, et al.
Published: (2024-01-01)

A SelectMDx/magnetic resonance imaging‐based nomogram to diagnose prostate cancer
by: Vinayak G. Wagaskar, et al.
Published: (2023-01-01)

DETECTION OF SPECIFIC CHROMOSOMAL REARRANGEMENT IN LEUKEMIA PATIENTS BY mDx HEMAVISION KIT
by: Tadej Pajič, et al.
Published: (2004-12-01)

Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging
by: Ricardo deAlmeida S Jr, et al.
Published: (2023-09-01)

Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: Result from bladder cancer Italian active surveillance (BIAS) project
by: N. Frego, et al.
Published: (2020-07-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Update on the potential role of micro-ultrasound in the differentiation between muscle-invasive and non-muscle invasive bladder cancer
by: A. Uleri, et al.
Published: (2020-10-01)

The utility of micro-ultrasound in patients under active surveillance for low-risk prostate cancer: A PRIAS study extension
by: D. Maffei, et al.
Published: (2020-07-01)

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice
by: D. Feder, et al.
Published: (2014-11-01)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
by: Simone Scuderi, et al.
Published: (2023-06-01)

Comparative lipidomic and metabolomic profiling of mdx and severe mdx-apolipoprotein e-null mice
by: Ram B. Khattri, et al.
Published: (2024-12-01)

Extracorporeal Circulation as a New Experimental Pathway for Myoblast Implantation in mdx Mice
by: Y. Torrente, et al.
Published: (1999-05-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-11-01)

A comparison of the bone and growth phenotype of mdx, mdx:Cmah−/− and mdx:Utrn+/− murine models with the C57BL/10 wild-type mouse
by: Claire L. Wood, et al.
Published: (2020-02-01)

Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
by: Jacob Fredsøe, et al.
Published: (2022-09-01)

Fast track to MDX /
by: Whitehorn, Mark, 1953-, et al.
Published: (2006)

Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
by: Blain, A, et al.
Published: (2018)

Heregulin ameliorates the dystrophic phenotype in mdx mice.
by: Krag, T, et al.
Published: (2004)

Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells.
by: Chunli Zhao, et al.
Published: (2014-01-01)

UNUSUAL BEHAVIOR OF THE GE DX CENTER IN GAAS - COEXISTENCE OF 2 LOCALIZED DONOR STATES
by: Vanderwel, P, et al.
Published: (1993)

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
by: Fisher, R, et al.
Published: (2000)

Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.
by: Yusuke Echigoya, et al.
Published: (2013-01-01)

QanikDX OÜ
by: Sergey Babichenko
Published: (2023-11-01)

DX and Dynamic Pricing
by: Satoru Shibuya
Published: (2022-01-01)

Validation of Plateletworks ADP for the ProCyte Dx analyzer
by: Matthew R. Kornya, et al.
Published: (2023-03-01)

Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs ± the nNOS-binding site
by: S. E. Hamm, et al.
Published: (2023-06-01)

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
by: Fisher, R, et al.
Published: (2001)

Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
by: Alison M Blain, et al.
Published: (2018-01-01)

Increased susceptibility of the dystrophic mdx mouse heart to ischemic and hypoxic injuries
by: Zhang, W, et al.
Published: (2005)

Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.
by: Francisco Altamirano, et al.
Published: (2014-01-01)

Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
by: Bruce E Markham, et al.
Published: (2015-01-01)

Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle
by: Eghtesad, Saman, et al.
Published: (2014)

Identification of a novel muscle targeting peptide in mdx mice.
by: Seow, Y, et al.
Published: (2010)

Gynecomastia: The 4Dx technique
by: Aakanksha Goel, et al.
Published: (2024-12-01)

T-cell-dependent fibrosis in the mdx dystrophic mouse.
by: Morrison, J, et al.
Published: (2000)

Decrease in prosaposin in the Dystrophic mdx mouse brain.
by: Hui-Ling Gao, et al.
Published: (2013-01-01)

An improved method for measuring muon energy using the truncated mean of dE/dx
by: collaboration, I, et al.
Published: (2012)

Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice
by: Stevens Paula J, et al.
Published: (2007-07-01)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
by: Rafael, J, et al.
Published: (2000)